查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678542

北美和歐洲敗血症診斷市場：市場規模、佔有率、趨勢分析（按產品、技術、病原體、測試方法、診斷方法、最終用途和國家）、細分市場預測（2025-2030 年）

North America And Europe Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Pathogen, By Testing, By Method, By End Use, By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

北美和歐洲敗血症診斷市場的成長和趨勢：

根據 Grand View Research, Inc. 的一份新報告，北美和歐洲敗血症診斷市場規模預計到 2030 年將達到 12.4 億美元，預測期內的複合年成長率為 7.3%。

敗血症在北美十分常見，是醫院死亡的主要原因。如此高的發病率推動了對有效診斷解決方案的需求。優惠的報銷政策也鼓勵醫療保健提供者採用先進的診斷方法，同時提高意識以及公共和私人資金正在支持創新工具的開發。

在歐洲，嚴格的法規確保了敗血症檢測的可靠性，從而支持了市場的成長。人口老化使得人們更容易感染疾病，這進一步增加了對客製化診斷解決方案的需求。此外，醫療支出的增加也提高了歐洲國家獲得先進診斷服務的機會。

歐洲疾病預防控制中心 (ECDC) 在 2024 年報告稱，每年約有 450 萬名患者感染 HAI，主要後果是敗血症。針對2023年，英國政府已撥款約1,200萬美元用於抗菌素抗藥性（AMR）研究，並直接支持敗血症管理舉措。此外，在美國，聯邦政府對敗血症計畫的資助預計到 2024 年將超過 5,000 萬美元，目標是改善診斷技術並降低敗血症相關的死亡率。

北美和歐洲敗血症診斷市場報告重點：

  • 按產品分類，血液培養基將在 2023 年佔據 30.0% 以上的市場佔有率，而檢測套件和試劑將在 2025 年至 2030 年間實現良好成長。
  • 微生物學將在 2024 年引領技術領域，預計分子診斷在預測期內將實現最快的成長，達到 9.3%。
  • 根據病原體，細菌性敗血症將在 2024 年佔據最大的市場佔有率，這得益於死亡率的大幅上升、醫院感染數量的增加以及技術的進步。預計在預測期內，其複合年成長率也將最快。
  • 根據測試技術，臨床測試引領測試領域，而 POC 測試預計將以驚人的 9.6% 的複合年成長率成長。
  • 基於診斷技術，自動診斷預計在預測期內以最快的複合年成長率成長。
  • 北美敗血症診斷市場由美國主導。向基於價值的護理的轉變正在鼓勵早期發現，而支持性報銷、提高意識和政府舉措正在加強敗血症管理創新。
  • 英國敗血症診斷市場預計將以歐洲市場中最快的速度成長，預測期內成長率為 8.1%。
  • 2024 年 3 月，BD 與波蘭 GOCC 合作，增加獲得先進血流感染檢測的機會，並在 150 多家醫院和診所部署最先進的微生物學設備，以改善敗血症管理。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 北美和歐洲敗血症診斷市場：促進因素、趨勢和範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析

4. 北美和歐洲敗血症診斷市場：按產品分類的業務分析

  • 按產品市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依產品
  • 依產品分類的市場規模預測及趨勢分析（2018-2030）
  • 裝置
  • 血培養基
  • 檢測試劑套件和試劑
  • 軟體

5. 北美和歐洲敗血症診斷市場：按技術分類的商業分析

  • 按技術分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依技術
  • 市場規模預測及技術趨勢分析（2018-2030）
  • 微生物學
  • 分子診斷
  • 免疫檢測
  • 流式細胞技術
  • 其他

6. 北美和歐洲敗血症診斷市場：按病原體進行的商業分析

  • 病原體市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依病原體
  • 病原體市場規模預測及趨勢分析（2018-2030）
  • 細菌性敗血症
  • 黴菌性敗血症
  • 病毒性敗血症
  • 其他

7. 北美和歐洲敗血症診斷市場：按測試方法的商業分析

  • 按測試方法分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依測試方法
  • 依測試方法分類的市場規模預測及趨勢分析（2018-2030）
  • 實驗室測試
  • PoC 測試

8. 北美和歐洲敗血症診斷市場：按診斷方法的商業分析

  • 按診斷方法分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：按診斷
  • 診斷方法的市場規模預測及趨勢分析（2018-2030年）
  • 自動診斷
  • 常規診斷

9. 北美和歐洲敗血症診斷市場-按最終用途進行的商業分析

  • 按最終用途分類的市場佔有率（2024 年和 2030 年）
  • 細分儀表板：依最終用途
  • 按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院和診所
  • 病理學和參考實驗室
  • 研究機構等

第 10 章 北美和歐洲敗血症診斷市場：各地區估計和趨勢

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 按國家/地區分類（2018-2030 年）
    • 美國
    • 加拿大
  • 歐洲
    • 按國家/地區分類（2018-2030 年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 挪威
    • 丹麥
    • 瑞典

第11章 競爭格局

  • 參與企業概況
  • 公司市場地位分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • BD
    • bioMerieux SA
    • Thermo Fisher Scientific Inc.
    • Beckman Coulter, Inc.（Danaher Corporation）
    • F. Hoffmann-La Roche Ltd
    • Cepheid
    • Luminex Corp.
    • Koninklijke Philips NV
    • Bruker
    • Immunexpress Inc.
Product Code: GVR-4-68040-511-8

North America And Europe Sepsis Diagnostics Market Growth & Trends:

The North America and Europe sepsis diagnostics market size is anticipated to reach USD 1.24 billion by 2030 and is anticipated to expand at a CAGR of 7.3% during the forecast period, according to a new report by Grand View Research, Inc. North America experiences a significant prevalence of sepsis, making it a leading cause of hospital deaths. This high incidence drives the demand for effective diagnostic solutions. Favorable reimbursement policies also encourage healthcare providers to adopt advanced diagnostics, while increased awareness and public-private funding boost the development of innovative tools.

In Europe, stringent regulations ensure reliable sepsis testing methods are available, supporting market growth. The aging population, more susceptible to infections, further escalates the demand for tailored diagnostic solutions. In addition, the rising healthcare spending enhances access to advanced diagnostics across European countries.

The European Centre for Disease Prevention and Control (ECDC) reported in 2024 that HAIs affected around 4.5 million patients annually, with sepsis as a major consequence. In 2023, the UK government allocated approximately USD 12 million for antimicrobial resistance (AMR) research, directly aiding sepsis management initiatives. Moreover, projected federal funding for sepsis-related programs in the U.S. was expected to exceed USD 50 million in 2024, aimed at improving diagnostic technologies and reducing mortality rates associated with sepsis.

North America And Europe Sepsis Diagnostics Market Report Highlights:

  • Based on product, blood culture media held over 30.0% market share in 2023, while assay kits and reagents are poised for lucrative growth from 2025 to 2030 onwards
  • Microbiology led the technology segment in 2024, while molecular diagnostics are anticipated to witness the fastest rate of 9.3% over the forecast period
  • Based on pathogen, bacterial sepsis held the largest market share in 2024, driven by significant mortality rates, rising HAIs, and technological advancements. It is also expected to grow at the fastest CAGR over the forecast period
  • Based on testing, POC testing is expected to grow at a staggering 9.6% CAGR as laboratory testing led the testing segment
  • Based on method, automated diagnostic methods are expected to grow at the fastest CAGR over the forecast period
  • The U.S. dominated the North America sepsis diagnostics market as the shift to value-based care promotes early detection, while supportive reimbursement, increased awareness, and government initiatives enhance sepsis management innovations.
  • The UK sepsis diagnostics market is expected to grow at the fastest rate of 8.1% over the forecast period in the Europe market
  • In March 2024, BD collaborated with GOCC in Poland to enhance access to advanced bloodstream infection testing, deploying state-of-the-art microbiology equipment across over 150 hospitals and clinics for improved sepsis management

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Pathogen
    • 1.2.4. Testing
    • 1.2.5. Method
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. North America and Europe Sepsis Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. North America and Europe Sepsis Diagnostics Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Blood Culture Media
    • 4.5.1. Blood Culture Media Market, 2018 - 2030 (USD Million)
  • 4.6. Assay Kits and Reagents
    • 4.6.1. Assay Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software Market, 2018 - 2030 (USD Million)

Chapter 5. North America and Europe Sepsis Diagnostics Market: Technology Business Analysis

  • 5.1. Technology Market Share, 2024 & 2030
  • 5.2. Technology Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Microbiology
    • 5.4.1. Microbiology Market, 2018 - 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.5.2. Polymerase Chain Reaction (PCR)
      • 5.5.2.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)
    • 5.5.3. DNA Microarrays
      • 5.5.3.1. DNA Microarrays Market, 2018 - 2030 (USD Million)
    • 5.5.4. Syndromic Panel Testing
      • 5.5.4.1. Syndromic Panel Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market, 2018 - 2030 (USD Million)
  • 5.6. Immunoassays
    • 5.6.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.7. Flow Cytometry
    • 5.7.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. North America and Europe Sepsis Diagnostics Market: Pathogen Business Analysis

  • 6.1. Pathogen Market Share, 2024 & 2030
  • 6.2. Pathogen Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Pathogen, 2018 to 2030 (USD Million)
  • 6.4. Bacterial Sepsis
    • 6.4.1. Bacterial Sepsis Market, 2018 - 2030 (USD Million)
    • 6.4.2. Gram-positive Bacteria
      • 6.4.2.1. Gram-positive Bacteria Market, 2018 - 2030 (USD Million)
    • 6.4.3. Gram-negative Bacteria
      • 6.4.3.1. Gram-negative Bacteria Market, 2018 - 2030 (USD Million)
  • 6.5. Fungal Sepsis
    • 6.5.1. Fungal Sepsis Market, 2018 - 2030 (USD Million)
  • 6.6. Viral Sepsis
    • 6.6.1. Viral Sepsis Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. North America and Europe Sepsis Diagnostics Market: Testing Business Analysis

  • 7.1. Testing Market Share, 2024 & 2030
  • 7.2. Testing Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Testing, 2018 to 2030 (USD Million)
  • 7.4. Laboratory Testing
    • 7.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
  • 7.5. PoC Testing
    • 7.5.1. PoC Testing Market, 2018 - 2030 (USD Million)

Chapter 8. North America and Europe Sepsis Diagnostics Market: Method Business Analysis

  • 8.1. Method Market Share, 2024 & 2030
  • 8.2. Method Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 8.4. Automated Diagnostics
    • 8.4.1. Automated Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5. Conventional Diagnostics
    • 8.5.1. Conventional Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. North America and Europe Sepsis Diagnostics Market: End Use Business Analysis

  • 9.1. End Use Market Share, 2024 & 2030
  • 9.2. End Use Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 9.4. Hospitals & Clinics
    • 9.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 9.5. Pathology & Reference Laboratories
    • 9.5.1. Pathology & Reference Laboratories Market, 2018 - 2030 (USD Million)
  • 9.6. Research Institutes and Others
    • 9.6.1. Research Institutes and Others Market, 2018 - 2030 (USD Million)

Chapter 10. North America and Europe Sepsis Diagnostics Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Share Analysis, 2024 & 2030
  • 10.2. Regional Market Dashboard
  • 10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 10.4. North America
    • 10.4.1. North America Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.4.2. U.S.
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Regulatory Framework
      • 10.4.2.3. Competitive Insights
      • 10.4.2.4. U.S. Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Canada
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Regulatory Framework
      • 10.4.3.3. Competitive Insights
      • 10.4.3.4. Canada Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Europe
    • 10.5.1. Europe Sepsis Diagnostics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.5.2. UK
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Regulatory Framework
      • 10.5.2.3. Competitive Insights
      • 10.5.2.4. UK Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. Germany
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Regulatory Framework
      • 10.5.3.3. Competitive Insights
      • 10.5.3.4. Germany Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. France
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Regulatory Framework
      • 10.5.4.3. Competitive Insights
      • 10.5.4.4. France Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. Italy
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Regulatory Framework
      • 10.5.5.3. Competitive Insights
      • 10.5.5.4. Italy Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. Spain
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Regulatory Framework
      • 10.5.6.3. Competitive Insights
      • 10.5.6.4. Spain Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Russia
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Regulatory Framework
      • 10.5.7.3. Competitive Insights
      • 10.5.7.4. Russia Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.8. Norway
      • 10.5.8.1. Key Country Dynamics
      • 10.5.8.2. Regulatory Framework
      • 10.5.8.3. Competitive Insights
      • 10.5.8.4. Norway Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.9. Denmark
      • 10.5.9.1. Key Country Dynamics
      • 10.5.9.2. Regulatory Framework
      • 10.5.9.3. Competitive Insights
      • 10.5.9.4. Denmark Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 10.5.10. Sweden
      • 10.5.10.1. Key Country Dynamics
      • 10.5.10.2. Regulatory Framework
      • 10.5.10.3. Competitive Insights
      • 10.5.10.4. Sweden Sepsis Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Participant Overview
  • 11.2. Company Market Position Analysis
  • 11.3. Company Categorization
  • 11.4. Strategy Mapping
  • 11.5. Company Profiles/Listing
    • 11.5.1. BD
      • 11.5.1.1. Overview
      • 11.5.1.2. Financial Performance
      • 11.5.1.3. Product Benchmarking
      • 11.5.1.4. Strategic Initiatives
    • 11.5.2. bioMerieux SA
      • 11.5.2.1. Overview
      • 11.5.2.2. Financial Performance
      • 11.5.2.3. Product Benchmarking
      • 11.5.2.4. Strategic Initiatives
    • 11.5.3. Thermo Fisher Scientific Inc.
      • 11.5.3.1. Overview
      • 11.5.3.2. Financial Performance
      • 11.5.3.3. Product Benchmarking
      • 11.5.3.4. Strategic Initiatives
    • 11.5.4. Beckman Coulter, Inc. (Danaher Corporation)
      • 11.5.4.1. Overview
      • 11.5.4.2. Financial Performance
      • 11.5.4.3. Product Benchmarking
      • 11.5.4.4. Strategic Initiatives
    • 11.5.5. F. Hoffmann-La Roche Ltd
      • 11.5.5.1. Overview
      • 11.5.5.2. Financial Performance
      • 11.5.5.3. Product Benchmarking
      • 11.5.5.4. Strategic Initiatives
    • 11.5.6. Cepheid
      • 11.5.6.1. Overview
      • 11.5.6.2. Financial Performance
      • 11.5.6.3. Product Benchmarking
      • 11.5.6.4. Strategic Initiatives
    • 11.5.7. Luminex Corp.
      • 11.5.7.1. Overview
      • 11.5.7.2. Financial Performance
      • 11.5.7.3. Product Benchmarking
      • 11.5.7.4. Strategic Initiatives
    • 11.5.8. Koninklijke Philips N.V.
      • 11.5.8.1. Overview
      • 11.5.8.2. Financial Performance
      • 11.5.8.3. Product Benchmarking
      • 11.5.8.4. Strategic Initiatives
    • 11.5.9. Bruker
      • 11.5.9.1. Overview
      • 11.5.9.2. Financial Performance
      • 11.5.9.3. Product Benchmarking
      • 11.5.9.4. Strategic Initiatives
    • 11.5.10. Immunexpress Inc.
      • 11.5.10.1. Overview
      • 11.5.10.2. Financial Performance
      • 11.5.10.3. Product Benchmarking
      • 11.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America and Europe sepsis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America and Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5. North America and Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6. North America and Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 7. North America and Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 8. North America and Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 9. North America and Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. North America sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 11. North America sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 12. North America sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 13. North America sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 14. North America sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 15. North America sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 16. North America sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17. U.S. sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 18. U.S. sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19. U.S. sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 20. U.S. sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 21. U.S. sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 22. U.S. sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Canada sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 24. Canada sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 25. Canada sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 26. Canada sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 27. Canada sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 28. Canada sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Europe sepsis diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 30. Europe sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 31. Europe sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32. Europe sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 33. Europe sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 34. Europe sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 35. Europe sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 36. UK sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 37. UK sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38. UK sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 39. UK sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 40. UK sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 41. UK sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Germany sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 43. Germany sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44. Germany sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 45. Germany sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 46. Germany sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 47. Germany sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48. France sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49. France sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50. France sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 51. France sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 52. France sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 53. France sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Italy sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 55. Italy sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56. Italy sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 57. Italy sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 58. Italy sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 59. Italy sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Spain sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 61. Spain sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 62. Spain sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 63. Spain sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 64. Spain sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 65. Spain sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Russia sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67. Russia sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68. Russia sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 69. Russia sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 70. Russia sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 71. Russia sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 72. Denmark sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73. Denmark sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 74. Denmark sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 75. Denmark sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 76. Denmark sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 77. Denmark sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78. Sweden sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79. Sweden sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80. Sweden sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 81. Sweden sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 82. Sweden sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 83. Sweden sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 84. Norway sepsis diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 85. Norway sepsis diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 86. Norway sepsis diagnostics market, by pathogen, 2018 - 2030 (USD Million)
  • Table 87. Norway sepsis diagnostics market, by testing, 2018 - 2030 (USD Million)
  • Table 88. Norway sepsis diagnostics market, by method, 2018 - 2030 (USD Million)
  • Table 89. Norway sepsis diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America and Europe sepsis diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and technology outlook (USD Million)
  • Fig. 10 Pathogen and testing outlook (USD Million)
  • Fig. 11 Method and end use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 North America and Europe sepsis diagnostics market dynamics
  • Fig. 14 North America and Europe sepsis diagnostics market: Porter's five forces analysis
  • Fig. 15 North America and Europe sepsis diagnostics market: PESTLE analysis
  • Fig. 16 North America and Europe sepsis diagnostics market: Product segment dashboard
  • Fig. 17 North America and Europe sepsis diagnostics market: Product market share analysis, 2024 & 2030
  • Fig. 18 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 19 Blood culture media market, 2018 - 2030 (USD Million)
  • Fig. 20 Assay kits and reagents market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 North America and Europe sepsis diagnostics market: Technology segment dashboard
  • Fig. 23 North America and Europe sepsis diagnostics market: Technology market share analysis, 2024 & 2030
  • Fig. 24 Microbiology market, 2018 - 2030 (USD Million)
  • Fig. 25 Molecular diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 26 Polymerase chain reaction (PCR) market, 2018 - 2030 (USD Million)
  • Fig. 27 DNA microarrays market, 2018 - 2030 (USD Million)
  • Fig. 28 Syndromic panel testing market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Immunoassays market, 2018 - 2030 (USD Million)
  • Fig. 31 Flow cytometry market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 North America and Europe sepsis diagnostics market: Pathogen segment dashboard
  • Fig. 34 North America and Europe sepsis diagnostics market: Pathogen market share analysis, 2024 & 2030
  • Fig. 35 Bacterial sepsis market, 2018 - 2030 (USD Million)
  • Fig. 36 Gram-positive bacteria market, 2018 - 2030 (USD Million)
  • Fig. 37 Gram-negative bacteria market, 2018 - 2030 (USD Million)
  • Fig. 38 Fungal sepsis market, 2018 - 2030 (USD Million)
  • Fig. 39 Viral sepsis market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 North America and Europe sepsis diagnostics market: Testing segment dashboard
  • Fig. 42 North America and Europe sepsis diagnostics market: Testing market share analysis, 2024 & 2030
  • Fig. 43 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 44 PoC testing market, 2018 - 2030 (USD Million)
  • Fig. 45 North America and Europe sepsis diagnostics market: Method segment dashboard
  • Fig. 46 North America and Europe sepsis diagnostics market: Method market share analysis, 2024 & 2030
  • Fig. 47 Automated diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 48 Conventional diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 49 North America and Europe sepsis diagnostics market: End use segment dashboard
  • Fig. 50 North America and Europe sepsis diagnostics market: End use market share analysis, 2024 & 2030
  • Fig. 51 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 52 Pathology & reference laboratories market, 2018 - 2030 (USD Million)
  • Fig. 53 Research institutes and others market, 2018 - 2030 (USD Million)
  • Fig. 54 North America and Europe sepsis diagnostics market revenue, by region
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 North America sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. country dynamics
  • Fig. 59 U.S. sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 60 Canada country dynamics
  • Fig. 61 Canada sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 UK country dynamics
  • Fig. 64 UK sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 65 Germany country dynamics
  • Fig. 66 Germany sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 67 France country dynamics
  • Fig. 68 France sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy country dynamics
  • Fig. 70 Italy sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain country dynamics
  • Fig. 72 Spain sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 73 Russia country dynamics
  • Fig. 74 Russia sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 75 Norway country dynamics
  • Fig. 76 Norway sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 77 Sweden country dynamics
  • Fig. 78 Sweden sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark country dynamics
  • Fig. 80 Denmark sepsis diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework